NCT05371197 2022-05-12Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal CancerThird Affiliated Hospital, Sun Yat-Sen UniversityPhase 2 Unknown26 enrolled